4
Changes in Ownership
Prime Medicine, Inc. Filed Acc 0001628280-22-027122
Director bought 400,000 shares at $17.00 ($6,800,000)
- Director acquired 4,905,679 shares (conversion)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Cahill Thomas Director | 2022-10-24 | Conversion | +4,905,679 | 4,905,679 | I | ||
| Cahill Thomas Director | 2022-10-24 | Purchase | +400,000 | $17.00 | $6,800,000 | 5,305,679 | I |
| Derivatives | |||||||
| Cahill Thomas Director | 2022-10-24 | Conversion · Series A Convertible Preferred Stock | −9,999,999 | 0 | I | ||
| Cahill Thomas Director | 2022-10-24 | Conversion · Series B Convertible Preferred Stock | −5,250,781 | 0 | I | ||
| Open-market purchases · 400,000 sh · avg $17.00 · $6,800,000 | |||||||
Loading xslF345X03/wf-form4_166682881646748.xml…